Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

EPI-Q, Inc.

EPI-Q, Inc. is listed as a consultant research supplier in the Scientist.com network, with 1 site in 1 country.

View EPI-Q, Inc. on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Consultant

Clinical Consulting

  • Study Budgeting Consulting Request for Consulting Services

Clinical Trials

  • Prospective Explorative Studies Conduct a prospective exploratory study to assess the safety and efficacy of a test drug during clinical trials.
  • Study/Site Feasibility Study Explore and test study practicality.

HEOR

  • Clinical Outcome Assessments (Non-Patient Reported) Measure a patient's symptoms, mental state and level of disease condition-related impact on daily life.
  • Clinical Outcomes Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
  • Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
  • Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
  • Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.
  • Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
Show all 13 in HEOR 7 more
  • Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
  • HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.
  • Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
  • Patient Treatment Patterns Assessment of treatment processes and patterns within clinical practice.
  • Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
  • Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
  • Therapy Switch Insight into the reasoning of patients switching treatments and the outcomes of the switch.

Market Access

  • Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
  • Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
  • Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
Show all 43 services 31 more

Medical/Commercial

  • Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.

Old Category HEOR, RWE, Market Access

  • Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
  • Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.
  • RWE/RWD Enriched Studies Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.

Real World Evidence & Data

  • Claims Data & Database Analysis Analysis of care cost and quality.
  • Claims Data - Medical Includes hospitalization,physician visits,emergency department visits. May or may not include laboratory information including resource utilization, costs or charges, as well as ICD-9 or 10 codes.
  • Clinical Data Registry A study or collection of data regarding the health of patients and the care they receive over different time periods.
  • Exploratory Study Explore study design, outcomes, data-collection method, and selection of population for a topic that needs more research information.
  • Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.
  • Non-Comparative Study Assess an intervention using a single arm study design (without a control or comparator group).
Show all 17 in Real World Evidence & Data 11 more
  • Patient Reported Outcomes (PRO) Databases Database or collection of data related to health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician or anyone else.
  • Pragmatic Clinical Trial Randomized trial comparing two or more treatments in a real world setting. The trial possesses minimal exclusion criteria and closely follows the procedures of the clinical practice in order to mirror clinical care...
  • Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
  • Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
  • Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
  • Registries - Disease Database containing, through utilizing observational research methods, standardized data about patients who have the same disease.
  • Registries - Patient Database containing, through utilizing observational research methods, standardized data about patients who have the same condition, disease, or exposure and is used to evaluate an outcome
  • Retrospective Exploratory Studies Retrospective exploratory studies
  • RWD - Electronic Medical Record (EMR) Digital version of a patient's medical or health chart containing demographic, clinical, medical, and other treatment information.
  • RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
  • Secondary Real World Evidence Analyze clinical trial data.

Regulatory Affairs

  • Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
  • Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.

Other services

  • Observational Research Gain valuable insights into the association between a drug treatment and its outcomes such as long-term effectiveness and safety.
Website
www.epi-q.com

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United States Oak Brook 1 site

Source: Scientist.com supplier network (site locations)

Get the EPI-Q, Inc. report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with EPI-Q, Inc. on Scientist.com

For prices, more details, or to contact EPI-Q, Inc., visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.